Latest filing published 08 Feb 2021 for Biolife Solutions INC, €288k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +32.3%Entry US$1.64 · Close at T+365 US$2.17
- -54.0%Entry US$5.04 · Close at T+365 US$2.32
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Walter Villiger: trading record in brief
All filings by Walter Villiger on record concern Biolife Solutions Inc. In total, 84 filings cover trades dated from 31 December 2005 to 5 February 2021.
On the open market, the record shows 19 purchases worth €1.3M and 52 sales worth €60.5M. Netting one side against the other leaves €59.2M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 8 share grants. So far in 2021, the count stands at no purchases and 15 sales.
Half of the purchases are above €48k and half below. After 4 purchases with a full 90-day history, the hit rate stands at 50% and the median 90-day move at +56.0%. This is a record of the past, not a forecast.
On 8 February 2021 came the latest disclosure, an open-market sale for €288k in Biolife Solutions Inc. The last insider purchase was made public on 20 November 2014, 4,371 days ago. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Walter Villiger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,538 shares@ US$40.650.4% of flowCommon StockSEC:0001437749-21-002264:0
- 40,000 shares@ US$40.902.0% of flowCommon StockSEC:0001437749-21-002264:1
- 29,811 shares@ US$42.481.5% of flowCommon StockSEC:0001437749-21-001310:0
- 50,000 shares@ US$41.582.5% of flowCommon StockSEC:0001437749-21-001310:1
- 40,000 shares@ US$40.301.9% of flowCommon StockSEC:0001437749-21-001039:0
- 29,182 shares@ US$41.031.4% of flowCommon StockSEC:0001437749-21-001039:1
- 22,152 shares@ US$43.081.1% of flowCommon StockSEC:0001437749-21-000907:0
- 29,338 shares@ US$40.621.4% of flowCommon StockSEC:0001437749-21-000907:1
- 40,000 shares@ US$40.201.9% of flowCommon StockSEC:0001437749-21-000682:0
- 27,277 shares@ US$40.351.3% of flowCommon StockSEC:0001437749-21-000682:1
- 12,723 shares@ US$40.130.6% of flowCommon StockSEC:0001437749-21-000682:2
- 8,435 shares@ US$40.400.4% of flowCommon StockSEC:0001437749-21-000682:3
- 18,948 shares@ US$42.540.9% of flowCommon StockSEC:0001437749-21-000443:0
- 15,075 shares@ US$41.530.7% of flowCommon StockSEC:0001437749-21-000443:1
- 30,000 shares@ US$39.551.4% of flowCommon StockSEC:0001437749-21-000443:2
- 40,000 shares@ US$32.332.1% of flowCommon StockSEC:0001437749-20-024297:0
- 36,848 shares@ US$33.352.0% of flowCommon StockSEC:0001437749-20-024297:1
- 36,957 shares@ US$31.681.9% of flowCommon StockSEC:0001437749-20-024182:0
- 40,000 shares@ US$31.312.0% of flowCommon StockSEC:0001437749-20-024182:1
- 32,596 shares@ US$32.841.7% of flowCommon StockSEC:0001437749-20-024050:0
- 48,306 shares@ US$31.972.5% of flowCommon StockSEC:0001437749-20-024050:1
- 50,000 shares@ US$32.002.6% of flowCommon StockSEC:0001437749-20-023705:0
- 50,000 shares@ US$32.982.7% of flowCommon StockSEC:0001437749-20-023705:1
- 100,000 shares@ US$32.535.3% of flowCommon StockSEC:0001437749-20-023059:0
- 34,480 shares@ US$31.751.8% of flowCommon StockSEC:0001437749-20-023059:1
25 of 79 declarations